Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power | FierceBiotech

Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power | FierceBiotech

More reads

• Treating diabetes by silencing IL-2's inflammatory power. (FierceBiotech)
• FDA clears RapidAI's blood clot detector. (MassDevice)
• Britain lines up more potential COVID-19 vaccine supplies with J&J, Novavax deals. (Reuters)